A share price of Veracyte Inc [VCYT] is currently trading at $30.32, up 1.95%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VCYT shares have gain 2.61% over the last week, with a monthly amount glided 1.34%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Veracyte Inc [NASDAQ: VCYT] stock has seen the most recent analyst activity on February 23, 2024, when Needham reiterated its Buy rating and also boosted its price target to $33 from $30. Previously, Raymond James downgraded its rating to Mkt Perform on January 18, 2023. On January 05, 2023, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $33 on the stock. Stephens started tracking the stock assigning a Overweight rating and suggested a price target of $52 on January 07, 2022. Raymond James started tracking with a Outperform rating for this stock on June 15, 2021, and assigned it a price target of $45.
Veracyte Inc experienced fluctuations in its stock price throughout the past year between $18.61 and $33.33. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Veracyte Inc [NASDAQ: VCYT] shares were valued at $30.32 at the most recent close of the market. An investor can expect a potential drop of -14.25% based on the average VCYT price forecast.
Analyzing the VCYT fundamentals
Trailing Twelve Months sales for Veracyte Inc [NASDAQ:VCYT] were 399.58M which represents 26.69% growth. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.14%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.05 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.63 points at the first support level, and at 28.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.79, and for the 2nd resistance point, it is at 31.25.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Veracyte Inc [NASDAQ:VCYT] is 4.44. In addition, the Quick Ratio stands at 4.17 and the Cash Ratio stands at 3.26. Considering the valuation of this stock, the price to sales ratio is 5.83, the price to book ratio is 2.05.
Transactions by insiders
Recent insider trading involved Leite John, Chief Commercial Officer-CLIA, that happened on Sep 04 ’24 when 5479.0 shares were sold. Officer, JOHN LEITE completed a deal on Sep 04 ’24 to buy 5479.0 shares. Meanwhile, Director JONES EVAN/ FA sold 27188.0 shares on Aug 13 ’24.
